Ceftazidime (injection)
سفتازیدیم (تزریقی)
🦠 Antiinfectives For Systemic UseAntipseudomonal third-generation cephalosporin
Market / country: 🇺🇸 USA
Fortaz (US)
🧮 Dose calculator
Sepsis / serious hospital infection (refer) · Regimen source: FDA Ceftazidime · Dosage and Administration, Table 3
- • Higher dose for immunocompromise, cystic fibrosis or meningitis. Reduce if GFR <50. FDA Ceftazidime · Dosage and Administration, Table 3FDA Ceftazidime · Dosage and Administration — Impaired Renal Function
Enter age and weight.
🛡️ Safety & information
Contraindications
- ⛔ Cephalosporin hypersensitivity; caution with penicillin allergy. FDA Ceftazidime · Contraindications
Formulations
- 1 g (reconstitute per label) — powder for injection 🇺🇸 USA FDA Ceftazidime · How Supplied
👥 Special populations
- 🤰 PregnancyUse with caution
Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Ceftazidime · Pregnancy
“Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.”
- 🤱 BreastfeedingUse with caution
Label: use with caution while breastfeeding; see the label text. FDA Ceftazidime · Nursing Mothers
“Caution should be exercised when ceftazidime is administered to a nursing woman.”
- 👶 ChildrenUse with caution
The label has conditions, age limits or notes for children; the label sentence is quoted below. FDA Ceftazidime · Pediatric Use
“(see DOSAGE AND ADMINISTRATION ).”
- 👴 Older adultsUse with caution
Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Ceftazidime · Geriatric Use
“Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function (see DOSAGE AND ADMINISTRATION ).”
- ⚥ Females & males of reproductive potentialNo data
The source for this drug has no section for this group.
🔗 Reference links
- FDA (approval record)ANDA062640
- DailyMed (FDA label)FDA Ceftazidime
- MedlinePlus (NIH)Ceftazidime Injection
- WHO ATC/DDDJ01DD02
- Darooyab (Iran)Ceftazidime
🇮🇷 Registered in Iran Darooyab · G-347/Ceftazidime
Dosage forms with Iranian generic codes, per Darooyab.
- 00230 · CEFTAZIDIME PENTAHYDRATE 1G VIAL · ویال سفتازیدیم پنتاهیدرات ۱ گرم
- 00231 · CEFTAZIDIME PENTAHYDRATE 2G VIAL · ویال سفتازیدیم پنتاهیدرات ۲ گرم
- 00232 · CEFTAZIDIME PENTAHYDRATE 500MG VIAL · ویال سفتازیدیم پنتاهیدرات ۵۰۰ میلیگرم
📚 Reference status for this drug
Shows which sources have references recorded for this drug and which do not.
- FDA label (DailyMed)✅ PresentFDA Ceftazidime · How SuppliedFDA Ceftazidime · Dosage and Administration, Table 3FDA Ceftazidime · Dosage and Administration — Impaired Renal FunctionFDA Ceftazidime · ContraindicationsFDA Ceftazidime · SPL approval / marketing categoryFDA Ceftazidime · PregnancyFDA Ceftazidime · Nursing MothersFDA Ceftazidime · Pediatric UseFDA Ceftazidime · Geriatric Use
- UK SmPC (eMC / MHRA)❌ Not present
- Published guideline❌ Not present
- Licensed reference (medical school)❌ Not present
- Iranian leaflet (IFDA)❌ Not present
- Pharmacy website (secondary, unreliable)✅ PresentDarooyab · G-347/Ceftazidime
- Clinical review⚠ Unverified